Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Cell
|
November 28, 2023
Prolonged sleep deprivation induces a cytokine-storm-like syndrome in mammals
Di Sang, Keteng Lin, Yini Yang, et al.
Molecular Cancer Therapeutics
|
December 29, 2011
CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers
Mangeng Cheng, Matthew R Quail, Diane E Gingrich, et al.
Pathology Oncology Research : POR
|
July 14, 2022
A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia Cells
Kunlong Zhang, Li Gao, Jianwei Wang, et al.
Journal of Immunology Research
|
September 28, 2023
Super Enhancer Regulatory Gene FYB1 Promotes the Progression of T Cell Acute Lymphoblastic Leukemia by Activating IGLL1
Kunlong Zhang, Jun Lu, Fang Fang, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of a potent inhibitor of anaplastic lymphoma kinase with in vivo antitumor activity
Gregory R Ott, Rabindranath Tripathy, Mangeng Cheng, et al.
Blood
|
October 29, 2005
Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells
Weihua Wan, Mark S Albom, Lihui Lu, et al.
Cancer Biology & Therapy
|
September 28, 2022
BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes
Li Ma, Jianwei Wang, Yongping Zhang, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 7, 2015
Piperidine-3,4-diol and piperidine-3-ol derivatives of pyrrolo[2,1-f][1,2,4]triazine as inhibitors of anaplastic lymphoma kinase
Eugen F Mesaros, Thelma S Angeles, Mark S Albom, et al.
Journal of Immunology Research
|
August 12, 2022
BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia
Xu Sang, Yongping Zhang, Fang Fang, et al.
Journal of Medicinal Chemistry
|
May 9, 2012
Discovery of an orally efficacious inhibitor of anaplastic lymphoma kinase
Diane E Gingrich, Joseph G Lisko, Matthew A Curry, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Cell
|
November 28, 2023
Prolonged sleep deprivation induces a cytokine-storm-like syndrome in mammals
Di Sang, Keteng Lin, Yini Yang, et al.
Molecular Cancer Therapeutics
|
December 29, 2011
CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers
Mangeng Cheng, Matthew R Quail, Diane E Gingrich, et al.
Pathology Oncology Research : POR
|
July 14, 2022
A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia Cells
Kunlong Zhang, Li Gao, Jianwei Wang, et al.
Journal of Immunology Research
|
September 28, 2023
Super Enhancer Regulatory Gene FYB1 Promotes the Progression of T Cell Acute Lymphoblastic Leukemia by Activating IGLL1
Kunlong Zhang, Jun Lu, Fang Fang, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of a potent inhibitor of anaplastic lymphoma kinase with in vivo antitumor activity
Gregory R Ott, Rabindranath Tripathy, Mangeng Cheng, et al.
Blood
|
October 29, 2005
Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells
Weihua Wan, Mark S Albom, Lihui Lu, et al.
Cancer Biology & Therapy
|
September 28, 2022
BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes
Li Ma, Jianwei Wang, Yongping Zhang, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 7, 2015
Piperidine-3,4-diol and piperidine-3-ol derivatives of pyrrolo[2,1-f][1,2,4]triazine as inhibitors of anaplastic lymphoma kinase
Eugen F Mesaros, Thelma S Angeles, Mark S Albom, et al.
Journal of Immunology Research
|
August 12, 2022
BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia
Xu Sang, Yongping Zhang, Fang Fang, et al.
Journal of Medicinal Chemistry
|
May 9, 2012
Discovery of an orally efficacious inhibitor of anaplastic lymphoma kinase
Diane E Gingrich, Joseph G Lisko, Matthew A Curry, et al.
Page
of 4